Case number 1:24-cv-00565
Exelixis, Inc. v. Cipla Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 10, 2024 | 12 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776 B2; 11,091,439 B2; 11,091,440 B2; 11,098,015 B2; 11,298,349 B2. (Attachments: # 1 Order)(nms) (Entered: 07/10/2024) (0) |
| Jul 9, 2024 | 11 | SO ORDERED Granting (D.I. 15 in 23-cv-287-RGA; D.I. 10 in 24-cv-565-RGA) Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 7/9/2024. Associated Cases: 1:24-cv-00565-RGA, 1:23-cv-00287-RGA(nms) (Entered: 07/09/2024) (2) |
| Jul 8, 2024 | 10 | STIPULATION of Dismissal Without Prejudice, by Exelixis, Inc.. (Raucci, Anthony) Modified on 7/9/2024 (nms). (Entered: 07/08/2024) (2) |
| Jun 13, 2024 | 9 | NOTICE requesting Clerk to remove Kevin M. Yurkerwich as co-counsel.. (Raucci, Anthony) (Entered: 06/13/2024) (3) |
| May 28, 2024 | 7 | WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Cipla Ltd. waiver sent on 5/22/2024, answer due 7/22/2024. (Raucci, Anthony) (Entered: 05/28/2024) (1) |
| May 28, 2024 | 8 | WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Cipla USA, Inc. waiver sent on 5/22/2024, answer due 7/22/2024. (Raucci, Anthony) (Entered: 05/28/2024) (1) |
| May 23, 2024 | N/A | CORRECTING ENTRY: Docket text of D.I. 3 has been modified to reflect the correct date Patentee(s) received notice. (mpb) (Entered: 05/23/2024) (0) |
| May 15, 2024 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (nms) (Entered: 05/15/2024) (0) |
| May 9, 2024 | 1 | COMPLAINT filed against Cipla Ltd., Cipla USA, Inc. (Filing fee $ 405, receipt number ADEDC-4403682.) - filed by Exelixis, Inc.. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(mpb) (Entered: 05/09/2024) (0) |
| May 9, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 05/09/2024) (3) |
| May 9, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/28/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/28/2026. (mpb) Modified on 5/23/2024 (mpb). (Entered: 05/09/2024) (1) |
| May 9, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776 B2; 11,091,439 B2; 11,091,440 B2; 11,098,015 B2 ; 11,298,349 B2. (mpb) (Entered: 05/09/2024) (1) |
| May 9, 2024 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Exelixis, Inc.. (mpb) (Entered: 05/09/2024) (1) |
| May 9, 2024 | 6 | Summonses Issued (please complete the top portion of the form and print out for use/service). (mpb) (Entered: 05/09/2024) (2) |
